2009
DOI: 10.4103/0378-6323.53150
|View full text |Cite
|
Sign up to set email alerts
|

Nifedipine-induced acute generalized exanthematous pustulosis in a case of acute glomerulonephritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…However, all clinical presentations of DIHS include end organ involvement, with possible renal, hepatic, cardiac or neurologic damage, which can be life threatening . AGEP‐DIHS overlap occurs most commonly in association with anti‐epileptics such as carbamazepineand phenytoin and has also been described with allopurinol . DIHS with features of AGEP have also been found in association with ibuprofen and mexiletine .…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…However, all clinical presentations of DIHS include end organ involvement, with possible renal, hepatic, cardiac or neurologic damage, which can be life threatening . AGEP‐DIHS overlap occurs most commonly in association with anti‐epileptics such as carbamazepineand phenytoin and has also been described with allopurinol . DIHS with features of AGEP have also been found in association with ibuprofen and mexiletine .…”
Section: Introductionmentioning
confidence: 98%
“…Specifically, sulfa medications have been reported to produce AGEP in oval erythematous and edematous plaques with pinpoint pustules . In addition, AGEP has been described with other atypical medication triggers including anti‐hypertensives (atenolol, nifedipine and diltiazem), antimycotics (terbinafineand itraconazole) antibiotics (minocycline, sulfapyridine and clindamycin), paracetamol, allopurinol, anti‐inflammatory medications (corticosteroids and oxicam NSAIDs, hydroxychloroquine, dexamethasone), icodextran (a peritoneal dialysate), and intravenous radiocontrast media . We highlight these medications to alert the clinician to the possibility of AGEP with atypical medication triggers.…”
Section: Introductionmentioning
confidence: 99%